Breast Cancer Risk, Cell Squeezing Technology, Microfluidics, Oncology Research, Machine Learning Healthcare, Cancer Screening, Mechanical Age Cells, Breast Cancer Diagnosis, AI in Oncology, Cell Mechanics, Predictive Medicine, Cancer Prevention, Biomedical Engineering, Clinical Innovation, Risk Assessment, oncology diagnostics innovation, cell mechanics cancer, early cancer risk detection, AI in breast cancer screening, personalized cancer risk, biomedical engineering oncology, cancer screening tools, predictive oncology
Breast Cancer Risk via Cell Squeezing Technology

Key Highlights Novel cell-squeezing technology assesses breast cancer risk at the cellular level. Microfluidic platform.

nivolumab, oral dysplasia, precancerous oral lesions, immunotherapy, checkpoint inhibitors, PD-1 inhibitor, oral cancer prevention, intralesional therapy, AACR 2026, head and neck oncology, cancer immunology, clinical trials oncology, MD Anderson research, minimally invasive oncology, tumor microenvironment, MD Anderson study, tumor immune response, CD8 T cell activation, non surgical cancer treatment, early cancer intervention, oncology clinical trial results
Nivolumab Reduces Oral Cancer Risk in Phase I Trial

Key Highlights Intralesional nivolumab reduced lesion size in 85% of patients 60% average shrinkage; 65%.

Breast Cancer, Aging, Breast Tissue, Oncology, Menopause, Immune System, Cancer Risk, Cell Atlas, Women’s Health, Tumor Microenvironment, Preventive Oncology, Hormonal Changes, Clinical Research, Cancer Biology, Screening, breast cell atlas, oncology research, cancer prevention, epithelial cells breast, stromal cells cancer, breast tissue aging, women cancer risk, inflammatory microenvironment, breast cancer biology, age related cance
Breast Cancer Risk Rises with Aging Tissue Changes

Key Highlights A 3-million-cell atlas reveals how aging reshapes breast tissue Decline in immune surveillance.

Exercise during chemotherapy, chemo brain, cancer exercise research, oncology supportive care, exercise oncology, chemotherapy cognitive effects, cancer patient exercise, EXCAP program, cancer fatigue management, oncology clinical trials, chemotherapy side effects, walking exercise cancer patients, resistance band exercises cancer treatment, clinical trial cancer exercise, cancer cognitive health, chemotherapy physical activity, cancer patient rehabilitation
Exercise During Chemotherapy Supports Brain Health

Key Points Summary A nationwide clinical trial found that structured exercise during chemotherapy helps patients.

Pancreatic Cancer, Oligometastatic Pancreatic Cancer, Metastatic Pancreatic Cancer, Oncology Research, Cancer Treatment Strategies, Liver Metastases, Lung Metastases, Multidisciplinary Tumor Board, Radiotherapy, Oncology Imaging, CT Scan, MRI Liver Imaging, Cancer Surgery, Oncology Consensus, Cancer Research, pancreatic cancer radiotherapy, systemic chemotherapy pancreatic cancer, oncology consensus guidelines, multidisciplinary tumor board oncology, pancreatic cancer imaging CT MRI, oligometastasis definition cancer, pancreatic cancer treatment strategies, oncology research pancreatic cancer, Lancet Oncology study
Oligometastatic Pancreatic Cancer: New Global Consensus

Key Points Summary An international expert group has created the first consensus definition for oligometastatic.

Breast Cancer, Triple Negative Breast Cancer, High Fat Diet, Cancer Metabolism, Tumor Microenvironment, MMP1, Oncology Research, Precision Oncology, Dietary Conditions, Chemotherapy Response, Extracellular Matrix, Cancer Prognosis, Tumor Invasion, Nutritional Oncology, Plasma-like Medium, tumor microenvironment, dietary conditions in cancer, oncology nutrition research, chemotherapy response and diet, plasma-like tumor model, metabolic reprogramming in cancer, TNBC prognosis factors, cancer cell invasion
Breast Cancer Prognosis Linked to High-Fat Diet

Key Points A high-fat diet accelerated tumor growth in TNBC models. Increased MMP1 levels are.

Advanced Prostate Cancer, Liquid biopsy, ctDNA testing, mCRPC, Androgen receptor alterations, Precision oncology, PARP inhibitors, AR pathway inhibitors, Treatment resistance, Genomic profiling, metastatic castration-resistant prostate cancer, ctDNA testing, androgen receptor alterations, AR amplification, treatment resistance, precision oncology, PARP inhibitors, ARPIs, taxane chemotherapy, real-time molecular testing, genomic instability, BRCA reversion mutations, personalized cancer care
Advanced Prostate Cancer and Serial ctDNA Analysis

Key Takeaways Serial liquid biopsies using ctDNA show how metastatic castration-resistant prostate cancer (mCRPC) changes.

Nanovaccine, Nanovaccine design, HPV tumors, Structural nanomedicine, Spherical nucleic acids, Cancer immunotherapy, CD8 T cells, Head and neck cancer, Cervical cancer, Oncology research, Therapeutic cancer vaccine, Interferon gamma, Tumor immunology, Nanotechnology in medicine, Science Advances study, Translational oncology
Nanovaccine Design Boosts Immune Attack on HPV Tumors

Key Highlights Reconfiguring peptide orientation significantly strengthened the CD8+ T cell response. Surface-displayed antigen (N-terminus.

Liquid Biopsy, Epigenetic Instability, DNA methylation, Early cancer detection, Oncology diagnostics, Cell-free DNA, Cancer screening, Precision oncology, Molecular diagnostics, early cancer detection, DNA methylation variability, cell-free DNA testing, oncology diagnostics, Epigenetic Instability Index, cancer screening biomarkers, blood-based cancer test, precision oncology, lung cancer detection, breast cancer screening, machine learning in oncology, cancer epigenomics, molecular cancer diagnostics
Liquid Biopsy Measures Epigenetic Instability in Cancer

Key Takeaways Johns Hopkins researchers developed a novel liquid biopsy that detects early-stage cancers by.

Pancreatic Cancer, Pancreatic Cancer Research, Oncology News, Cancer Therapy, KRAS Mutation, Preclinical Cancer Studies, Oncology Research, Cancer Treatment Advances, CNIO, PNAS Study
Pancreatic Cancer Research: Triple-Drug Therapy Success

Key Summary Spanish researchers report complete tumour elimination in mouse models of aggressive Pancreatic Cancer.